04:03 PM EDT, 06/23/2025 (MT Newswires) -- Health care stocks were mixed late Monday afternoon, with the NYSE Health Care Index down 0.2% and the Health Care Select Sector SPDR Fund (XLV) adding 0.1%.

The iShares Biotechnology ETF (IBB) shed 0.5%.

In corporate news, Lineage Cell Therapeutics ( LCTX ) shares rose 2% after the firm said its phase 1/2a trial of OpRegen showed consistent improvement in visual acuity for 36 months in a subgroup of patients with geographic atrophy.

Novo Nordisk ( NVO ) ended its collaboration with Hims & Hers Health ( HIMS ) on the sale of weight loss drug Wegovy over concerns about "illegal mass compounding and deceptive marketing." Hims & Hers shares dropped 35%, and Novo was down 5.5%.

Exelixis ( EXEL ) shares rose past 7% after the firm said its phase 3 trial of zanzalintinib and atezolizumab combination showed a "statistically significant" overall survival benefit in patients with a type of metastatic colorectal cancer.